Fibrosarcoma, an aggressive and poorly understood form of soft tissue sarcoma, poses significant therapeutic challenges, and recent evidence suggests that the NF-κB pathway may play a key role in its progression or angiogenesis (46). Here, NFKB1 is linked to fibrosarcoma.